3M uses cookies on this site Detailed information on cookies and their use can be found in our Privacy Policy. You can customize the cookie-related settings at any time by clicking on Cookie Preferences in the footer of this page.

By clicking "Accept and Proceed" you acknowledge that you agree to the use of cookies on your computer

Accept and Proceed

Skip to Primary Navigation Skip to Site Navigation Skip to Main Content All 3M.com Site Map

Reducing Skin Recolonisation

Protect Your Patients

from Surgical Site Infection

Surgical site infections can result in extended hospital stays and patient mortality.1 You can better treat the source of surgical site infection if you reduce the number of bacteria on the skin to the lowest possible level with 3M™ Ioban™ Incise Drapes, which reduce contamination by forming a sterile physical barrier. They’ve been proven effective in a study that showed fewer colony forming units of bacteria on skin treated with 3M™ Ioban™ Incise Drapes compared with CHG, PVI or alcohol and non-iodophor impregnated incise drapes.8 Contact a Clinical Specialist to learn more about how 3M can partner with your organisation to best meet your needs.

Skin Recolonisation Facts: Did You Know?

Patients who acquire infection in the hospital stay 3 times longer.4

Approximately 20% of the resident flora is beyond the reach of surgical scrubs and antiseptics.5

Even after 3 hours, patients using alcohol and 3M™ Ioban™ 2 Incise Drapes had more than 50% fewer bacterial colony forming units (CFU) on their skin compared to other preparations.8

NICE Recommendation

NICE Recommendation


There are various causes of SSI's but the most common source is the patient's own skin flora.7 It is a constant battle to reduce skin recolonisation as skin flora keeps growing.5 The high probability of the entrance of bacteria should be a constant challenge to reduce such contamination.10


If an incise drape is required, use an iodophor impregnated drape unless the patient has an iodine allergy.6


3M™ Ioban™ 2 Antimicrobial Surgical Incise Drapes reduce the likelihood of skin recolonisation after prepping8, and thus reduce the risk of wound contamination by skin flora.9

Contact a Clinical Specialist to learn how 3M can partner with you to help reduce the risk of infection by becoming NICE compliant.

3M Products to Prevent Surgical Site Infection

3M Products to Help Reduce the Risk of Surgical Site Infection

Find the Ioban drape that is most appropriate for your procedure:

3M™ Ioban™ 2 Antimicrobial Incise Drapes
3M™ Ioban EZ Antimicrobial Incise Drapes
Orthopaedic Drapes
Cardiac Drapes
Neurosurgery Drapes
General Drapes
View all Incise Drape Products

Contact an expert for assistance from one of our infection control specialists to find the surgical incise drape that best meets your needs.

Contact an expert

Not All Surgical Incise Drapes Are the Same

Not All Surgical Incise Drapes Are the Same

3M™ Ioban™ Incise Drapes form a sterile, physical barrier around the incision site and bacterial skin recolonisation is reduced. They can be used on every patient*, providing peace of mind that all is being done to prevent wound contamination.

"Ioban surgical incise drapes are an essential part of a surgeon's care bundle to reduce the risk of SSIs and create a sterile field not achievable by skin preparation alone. The drape stays in place and the active agent keeps working."

- Mr. Philip Roberts
Consultant Orthopaedic Surgeon
University Hospital of North Staffordshire
January 2012


View Chart

When tested against 12 microorganisms commonly associated with SSI, the Ioban incise drapes were more effective than other antimicrobial surgical incise drapes2

View Chart


View Chart

A study shows fewer colony forming units of bacteria on skin treated with 3M™ Ioban™ Incise Drapes, compared with CHG, PVI or alcohol and non-iodophor impregnated incise drape8

View Chart

3M™ Ioban™ Incise Drape Customer Testimonials

What is the Impact of SSI on the surgeon and healthcare facility?

Risk of SSI

The risk of SSI has been shown to increase across all surgical categories where the wound class was dirty or contaminated, or for emergency procedures.3 Learn more about SSI identification by visiting our education and training site.

Infection Prevention e-Learning
Patient Mortality

Mortality figures are published for individual surgeons and it has been estimated that over one-third of post-operative deaths are related, in part, to SSI.1

Health Care Costs

Reported additional direct costs of between £814 and £6,626, according to surgery type and infection.1 However, also an opportunity cost: extra bed days mean operations are cancelled.

Extended Hospital Stays

SSI can double the length of time a patient stays in hospital, preventing other patients from receiving surgery.1

Patient Reported Outcome Measures (PROMS)

A selection of patients are interviewed following treatment and the results fed back to care providers to ensure quality. A poor outcome may mean a reduction in funding.

Contact a 3M Infection Prevention expert today and learn how a partnership can help you enhance your efforts to reduce surgical site infections and prevent skin recolonisation.

See All Products

Contact a Clinical Specialist


1NICE Clinical Guidance 74. Surgical site infection: prevention and treatment of surgical site infection. 2008

2Eyberg C, et al. Poster presented, Society of Healthcare Epidemiology of America, March 2009

3Health Protection Agency. Surveillance of Surgical Site Infections in NHS Hospitals in England. 2011/2012

4 Plowman R, Graves N, Griffin M et al (1999) The socio-economic burden of hospital acquired infection. London: Public Health Laboratory Service

5Sebben JE. J Am Acad Dermatol 1983; 9: 759-65

6NICE (2008) Clinical Guideline 74, Surgical Site Infections: Prevention and treatment of surgical site infection. Section 6.6

7 Whyte W, et al. J Hosp Infec 1991; 18: 93-107

8D.H. Johnston, J.A. Fairclough, et al. 1987 Rate of bacterial recolonization of the skin after preparation: four methods compared Br. J. Surg., Vol. 74, January, page 64.

9Professor John Fairclough, Consultant Orthopaedic Surgeon, University Hospital of Wales. 2010

10Lovell DL. Archives of Surgery. 1945.51:78-80

*Not to be used on neonates or those with an iodine allergy